Brussels, Friday 2 March 2017
Beloved Majesty King Mohammed VI and Beloved Royal Highness Princess Lalla Salma,
It concerns the creation of the a global network of Cancer U-turn Centers in cooperation with the Ananccell Biointelligence Corporation, a Moroccan company specializing in organic personalized cosmetics and in DNA-based pharmaceuticals.
The role of the Cancer U-turn Center is to provide a definitive answer on what cancer is precisely and what the cause is of this disease. It also aims to remove the cancer definitively from the global community, or at least to limit the threat of the further spread of it
It’s role is also to achieve the coordination response to the cancer pest as well as to facilitate joint research and development of innovative treatments and prevention programs.
The Cancer U-turn Center aims to collaborate in public and private partnerships involving the hospitals, the universities, the health authorities and the pharmaceutical industry among which the Anaccell Corporation.
The Anaccell Corporation is a scientific project, which specializes in research and development of drugs for diseases of unknown origin. It will supply the know-how for organizing the research, the production and the distribution of the DNA-based pharmaceuticals as well as the science for precision and efficiency.
The Anaccell Corporation aims to set the standards for the personalized pharmaceuticals
One component is the DNA-driven organization. For covering the global markets and for serving a wide range of DNA, the Anaccell Corporation will rely on a partnership with the Multicultural Innovation infrastructure which I will present to you next week, on Tuesday 7 March 2017, insha’Allah.
For now, I have the honor to provide a preview of the public private partnership proposal which I will publish in the next few weeks. by 15 March 2017, insha’Allah.
Help make our world safer, for the children. Spread your wealth through enterprise. Support Allah Ghaleb : IBAN BE08 0003 5445 8713